{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:36:40Z","timestamp":1792190200782,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ijpharm.2012.04.063","type":"journal-article","created":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T03:19:06Z","timestamp":1335842346000},"page":"1-10","source":"Crossref","is-referenced-by-count":80,"title":["Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models"],"prefix":"10.1016","volume":"432","author":[{"given":"Hamdy","family":"Abdelkader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raida","family":"Al-Kassas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raid G.","family":"Alany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.04.063_bib0005","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1208\/s12249-008-9105-1","article-title":"Niosome-encapsulated gentamicin for ophthalmic controlled delivery","volume":"9","author":"Abdelbary","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0010","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/jps.22422","article-title":"Design and evaluation of controlled release niosomes and discomes for naltrexone hydrochloride ocular delivery","volume":"100","author":"Abdelkader","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1442-9071.2010.02435.x","article-title":"New therapeutic approaches in treatment of diabetic keratopathy","volume":"39","author":"Abdelkader","year":"2011","journal-title":"Clin. Exp. Opthalmol."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1773-2247(11)50017-6","article-title":"Preformulation characteristics of the opioid growth factor antagonist-naltrexone hydrochloride: stability and lipophilicity studies","volume":"21","author":"Abdelkader","year":"2011","journal-title":"J. Drug Deliv. Sci. Tech."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2005.11.020","article-title":"W\/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention","volume":"111","author":"Alany","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0030","series-title":"The Status of Alternative Methods in Toxicology","first-page":"21","author":"Anderson","year":"1995"},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0035","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0012-1606(74)90316-9","article-title":"A simple procedure for the long-term cultivation of chicken embryos","volume":"41","author":"Auerbach","year":"1974","journal-title":"Dev. Biol."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0040","series-title":"Advances in Ocular Toxicology","first-page":"261","article-title":"Toxicity testing for ocular drug products","author":"Avalos","year":"1997"},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0045","article-title":"Toxic effects of drugs on the corneal epithelium: a review","volume":"2","author":"Basu","year":"1984","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0050","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/bjo.65.10.694","article-title":"Effect of hydrocortisone on the mobilization of leucocytes on the corneal wounds","volume":"65","author":"Basu","year":"1981","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0055","series-title":"In Vitro Toxicity Testing: Applications to Safety Evaluation","first-page":"149","article-title":"Ocular irritation","author":"Bruner","year":"1992"},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0060","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1556\/AVet.58.2010.3.9","article-title":"HET-CAM test for determining the possible eye irritancy of pesticides","volume":"58","author":"Budai","year":"2010","journal-title":"Acta Veter. Hung."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0065","series-title":"Handbook of Pharmaceutical Excipients","first-page":"155","article-title":"Cholesterol","author":"Buehler","year":"2003"},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0070","first-page":"243","article-title":"The application of Benchmarks for the evaluation of the potential ocular irritancy of aerosol fragrances","volume":"66","author":"Cuellar","year":"2002","journal-title":"The Toxicologist"},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0075","first-page":"557","article-title":"Correlation of histopathology, opacity and permeability of bovine corneas exposed in vitro to known ocular irritants","volume":"37","author":"Curren","year":"2000","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0080","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1289\/ehp.98106485","article-title":"In vitro alternatives for ocular irritation","volume":"106","author":"Curren","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0085","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/archopht.1981.03930011081019","article-title":"Ocular toxicity of topical antifungal agents","volume":"99","author":"Foster","year":"1981","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0090","doi-asserted-by":"crossref","DOI":"10.1208\/ps040102","article-title":"Ocular tolerance of absorption enhancers in ophthalmic preparations","volume":"4","author":"Furrer","year":"2002","journal-title":"AAPS PharmSci."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijpharm.2005.09.023","article-title":"Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide","volume":"306","author":"Guinedi","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0100","unstructured":"Harbell, J.W., Mun, G., Curren, R.D., 2006. Application of histological evaluation to enhance the bovine opacity and permeability (BCOP) assay. Paper presented at the 45th Annual Society of Toxicology Meeting, San Diego, CA, USA."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0105","first-page":"336","article-title":"Histopathology associated with opacity and permeability changes in bovine corneas in vitro","volume":"48","author":"Harbell","year":"1999","journal-title":"The Toxicologist"},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0110","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/01.ico.0000130417.91438.7e","article-title":"Reversible amantadine-induced corneal edema in an adolescent","volume":"23","author":"Hughes","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0115","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.2042-7158.1996.tb05923.x","article-title":"A novel method for the preclinical assessment of rectal irritation","volume":"48","author":"Kinouchi","year":"1996","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0120","series-title":"Modern Pharmaceutics","first-page":"626","article-title":"Design and evaluation of ophthalmic pharmaceutical products","author":"Lang","year":"2002"},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0125","series-title":"Handbook of Pharmaceutical Excipients","first-page":"591","article-title":"Sorbitan esters (sorbitan fatty acid esters)","author":"Lawrence","year":"2003"},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0130","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0278-6915(86)90100-6","article-title":"The chorioallantoic membrane in irritation testing","volume":"24","author":"Lawrence","year":"1986","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00002018-200831020-00003","article-title":"Drug-induced ocular disorders","volume":"31","author":"Li","year":"2008","journal-title":"Drug Saf."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0140","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0278-6915(85)90030-4","article-title":"Hen's egg chorioallantoic membrane test for irritation potential","volume":"23","author":"Luepke","year":"1985","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0145","first-page":"3","article-title":"Cornea","volume":"vol. 1","author":"Nishida","year":"2005"},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0150","first-page":"246","article-title":"The effects of ophthalmic drugs, vehicles, preservatives on corneal epithelium: a scanning electron microscope study","volume":"15","author":"Pfister","year":"1976","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0192623307310955","article-title":"Safety evaluation of ocular drug delivery formulations: techniques and practical considerations","volume":"36","author":"Short","year":"2008","journal-title":"Toxicologic Pathol."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0170","first-page":"515","article-title":"Validation of the Becam assay: an eye irritancy screening test","volume":"vol. 5","author":"Weterings","year":"1987"},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0175","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.2337\/diabetes.51.10.3055","article-title":"Naltrexone, an opioid antagonist, facilitates reepithelialization of the cornea in diabetic rat","volume":"51","author":"Zagon","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0180","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/jop.2006.22.377","article-title":"Corneal safety of topically applied naltrexone","volume":"22","author":"Zagon","year":"2006","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0185","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1001\/archophthalmol.2009.270","article-title":"Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus","volume":"127","author":"Zagon","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0190","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0006-8993(98)00610-6","article-title":"Re-epithelialization of the rabbit cornea is regulated by opioid growth factor","volume":"803","author":"Zagon","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0195","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0006-8993(98)00427-2","article-title":"Re-epithelialization of the rat cornea is accelerated by blockade of opioid receptors","volume":"798","author":"Zagon","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0200","first-page":"73","article-title":"Reepithelialization of the human cornea is regulated by endogenous opioids","volume":"41","author":"Zagon","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0205","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainresbull.2006.12.007","article-title":"Naltrexone accelerates healing without compromise of adhesion complexes in normal and diabetic corneal epithelium","volume":"72","author":"Zagon","year":"2007","journal-title":"Br. Res. Bull."},{"key":"10.1016\/j.ijpharm.2012.04.063_bib0210","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0165-0173(01)00160-6","article-title":"The biology of the opioid growth factor receptor(OGFr)","volume":"38","author":"Zagon","year":"2002","journal-title":"Br. Res. Rev."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312004097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312004097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T19:20:04Z","timestamp":1543000804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312004097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0378517312004097"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.04.063","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}